BMY
53
-7
JPM
55
2
DIS
58
-2
WHR
57
2
TRV
62
-2
MAT
54
3
OI
50
7
GT
50
4
HP
45
4
CTAS
58
2
MUR
52
3
SE
68
3
NWSA
49
2
AZO
43
-2
MCHP
49
7
AA
45
2
XRX
55
3
BRK.B
45
3
HRL
35
-3
V
56
-8
BMY
53
-7
JPM
55
2
DIS
58
-2
WHR
57
2
TRV
62
-2
MAT
54
3
OI
50
7
GT
50
4
HP
45
4
CTAS
58
2
MUR
52
3
SE
68
3
NWSA
49
2
AZO
43
-2
MCHP
49
7
AA
45
2
XRX
55
3
BRK.B
45
3
HRL
35
-3
V
56
-8
Financhill
Back

Janux Therapeutics Stock Predictions

Free 23-page book shares my #1 indicator to use

Here's the 23-page free book.
Sell
34

JANX
Janux Therapeutics

Last Price:
50.18
Seasonality Move:
-11.26%

7 Day Trial

ALL ACCESS PASS

$ 7

How to Profit From "America's Earnings" Reports

New Trade Goes LIVE THIS TUESDAY at 2 pm

Janux Therapeutics Stock Forecast

  • Over the next 52 weeks, Janux Therapeutics has on average historically risen by 78.6% based on the past 3 years of stock performance.
  • Janux Therapeutics has risen higher in 1 of those 3 years over the subsequent 52-week period, corresponding to a historical accuracy of 33.33%
  • Is Janux Therapeutics Stock Undervalued?
    The current Janux Therapeutics [JANX] share price is $50.03. The Score for JANX is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
  • JANX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will Janux Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, Janux Therapeutics has on average historically risen by 78.6% based on the past 3 years of stock performance.

Janux Therapeutics Stock Rating

Sell
34
Janux Therapeutics (JANX) is a Sell

Is Janux Therapeutics overpriced?

  • Janux Therapeutics has risen higher in 1 of those 3 years over the subsequent 52-week period, corresponding to a historical accuracy of 33.33%

Janux Therapeutics Stock Price History

Is JANX stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and JANX is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
januxrx.com

52-Week Data

52-Week High:
65.60
52-Week Low:
5.65

Prediction Charts

Market Cap:
2.61B
Price in USD:
50.03
Volume:
672.62K
Beta:
3.66

Technical Analysis

SMA50:
43.34
SMA100:
45.11
SMA200:
34.63
52-Wk Change:
418.98%

Stock Predictions

  • Is Janux Therapeutics stock public?
    Yes, Janux Therapeutics is a publicly traded company.
  • What is the Janux Therapeutics stock quote today?
    The Janux Therapeutics stock price is 50.03 USD today.
  • How to buy Janux Therapeutics stock online?
    You can buy Janux Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Aug-30 44.92 47.03 47.36 44.67
Sep-3 47.02 45.01 47.59 44.92
Sep-4 44.00 44.47 46.87 43.89
Sep-5 44.50 43.83 44.86 43.30
Sep-6 44.68 41.26 45.00 41.23
Sep-9 41.60 41.86 42.94 41.42
Sep-10 41.69 45.52 47.46 41.69
Sep-11 44.72 43.71 45.25 43.35
Sep-12 43.82 46.42 48.85 43.50
Sep-13 47.23 50.01 50.62 46.44
Sep-16 50.39 49.89 51.63 48.70
Sep-17 50.25 49.46 51.10 47.80
Sep-18 49.22 48.32 51.26 48.22
Sep-19 50.10 50.03 50.97 48.59

Janux Therapeutics Earnings

Janux Therapeutics Earnings Report: Per Share Janux Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Janux Therapeutics Forecast Revenue Growth

Janux Therapeutics Stock Analysis: Historical quarterly revenues per share for Janux Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.07 per share, a decrease next quarter of $0.07 per share, an increase this year of $0.19 per share, and a decrease next year of $0.46 per share.

* Janux Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.